"Six Corporate Oversights of Quality and Compliance Issues in Pharmaceutical Environments"
This white paper presents six significant quality and compliance oversights that pharmaceutical companies may unknowingly propagate or encourage over time.
At a corporate level, quality and compliance management in heavily regulated pharmaceutical environments is a tricky endeavor. After all, success in the areas of quality and compliance can only be achieved when a multitude of variables are controlled and continually maintained. This white paper will discuss how to improve upon:
Investment in CROs
Training for Corporate Personnel
Investment in Successful Technologies
Understanding and/or Investment in Pharmacovigilance and Pharmacoepidemiology
Understanding or Investment in Risk-Based Management